14.3加仓一成。

2017-08-17

$Adamas Pharmaceuticals, Inc.(ADMS)$
以及13.5加仓5成

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":85679,"tweetId":"85679","gmtCreate":1502914778399,"gmtModify":1704880191134,"author":{"id":3456416833532168,"authorId":3456416833532168,"authorIdStr":"3456416833532168","name":"阿里巴巴死多头","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":31,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"14.3加仓一成。","extraTitle":"","html":"<html><head></head><body>$Adamas Pharmaceuticals, Inc.(ADMS)$ 以及13.5加仓5成</body></html>","htmlText":"<html><head></head><body>$Adamas Pharmaceuticals, Inc.(ADMS)$ 以及13.5加仓5成</body></html>","text":"$Adamas Pharmaceuticals, Inc.(ADMS)$ 以及13.5加仓5成","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/85679","repostId":0,"isVote":1,"tweetType":1,"viewCount":1148,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ADMS"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":49,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/85679"}